11 research outputs found

    Remnant Trees in Enrichment Planted Gaps in Quintana Roo, Mexico: Reasons for Retention and Effects on Seedlings

    No full text
    Natural forest management in the tropics is often impeded by scarcity of advanced regeneration of commercial species. To supplement natural regeneration in a forest managed by a community in the Selva Maya of Mexico, nursery-grown Swietenia macrophylla seedlings were planted in multiple-tree felling gaps, known as bosquetes. Remnant trees are often left standing in gaps for cultural and economic reasons or due to their official protected status. We focus on these purposefully retained trees and their impacts on planted seedlings. Sampled bosquetes were 400–1800 m2, of which remnant trees covered a mean of 29%. Seedling height growth rates over the first 18 months after out-planting more than doubled with increased canopy openness from 0.09 m year−1 under medium cover to 0.22 m year−1 in full sun. Liana infestations and shoot tip damage were most frequent on seedlings in the open, but, contrary to our expectations, height growth rates were 0.14 m year−1 faster for liana-infested seedlings than non-infested and did not differ between damaged and undamaged seedlings. Apparently the more rapid height growth of well-illuminated seedlings more than compensated for the effects of lianas or shoot tip damage. Despite the abundance of remnant trees and their negative effects on seedling growth, enrichment planting in bosquetes has potential for community-based natural forest management in the tropics in supplementing natural regeneration of commercial species. One obvious recommendation is to leave fewer remnant trees, especially those of commercial species that are non-merchantable due to stem defects and trees retained for no apparent reason, which together constituted half of the remnant crown cover in the sampled bosquetes. Finally, given the rapid growth of lianas and understory palms in large canopy gaps, at least the most vigorous of the planted seedlings should be tended for at least two years

    Proteomic analysis of the esophageal epithelium reveals key features of eosinophilic esophagitis pathophysiology

    No full text
    Background Eosinophilic esophagitis (EoE) is a chronic non-IgE-mediated allergic disease of the esophagus. An unbiased proteomics approach was performed to investigate pathophysiological changes in esophageal epithelium. Additionally, an RNAseq-based transcriptomic analysis in paired samples was also carried out. Methods Total proteins were purified from esophageal endoscopic biopsies in a cohort of adult EoE patients (n = 25) and healthy esophagus controls (n = 10). Differentially accumulated (DA) proteins in EoE patients compared to control tissues were characterized to identify altered biological processes and signaling pathways. Results were also compared with a quantitative proteome dataset of the human esophageal mucosa. Next, results were contrasted with those obtained after RNAseq analysis in paired samples. Finally, we matched up protein expression with two EoE-specific mRNA panels (EDP and Eso-EoE panel). Results A total of 1667 proteins were identified, of which 363 were DA in EoE. RNA sequencing in paired samples identified 1993 differentially expressed (DE) genes. Total RNA and protein levels positively correlated, especially in DE mRNA-proteins pairs. Pathway analysis of these proteins in EoE showed alterations in immune and inflammatory responses for the upregulated proteins, and in epithelial differentiation, cornification and keratinization in those downregulated. Interestingly, a set of DA proteins, including eosinophil-related and secreted proteins, were not detected at the mRNA level. Protein expression positively correlated with EDP and Eso-EoE, and corresponded with the most abundant proteins of the human esophageal proteome. Conclusions We unraveled for the first time key proteomic features involved in EoE pathogenesis. An integrative analysis of transcriptomic and proteomic datasets provides a deeper insight than transcriptomic alone into understanding complex disease mechanisms.European Regional Development FundMinisterio de Ciencia e Innovación (MCIN)Ministerio de Trabajo y Economía SocialComunidad de MadridAsociacion Española de GastroenterologíaInstituto de Salud Carlos IIIDepto. de Biología CelularFac. de Ciencias BiológicasTRUEpu

    Encuentros urbanos. Red académica para estudios de ciudad. Habitat III

    No full text
    Encuentros Urbanos es una publicación producto del trabajo colaborativo de 10 instituciones académicas; una alianza que se presenta como un signo alentador de mayores posibilidades con respecto a nuevas perspectivas sobre la ciencia de la ciudad. La Red Académica para estudios de Ciudad, se conforma a raíz de hábitat III, celebrado en Quito en octubre de 2016. Si bien hábitat III fue pretexto ideal para su formación, esta red, que aspira a trascender dicho evento, establece a través de este libro un compromiso de apertura de puertas, de socialización de conocimientos y de potenciales colaboraciones futuras no solo a nivel local, sino a nivel internacional, con aportes de universidades extranjeras en este compendio. Lo que empezó como una serie de intenciones modestas y aisladas, es hoy un ambicioso proyecto que se manifiesta en este trabajo recopilatorio de las evidencias de los 10 Encuentros Urbanos celebrados en 2016. Según sus particulares enfoques, potencialidades y disciplinas de cada institución miembro de la red realizó interesantes aportes y estableció una serie de debates sobre la cuestión urbana, quedando abiertos a discusiones vigentes y a nuevas alianza

    mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

    No full text
    Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#termsActivation of the PTEN-PI3K-mTORC1 pathway consolidates metabolic programs that sustain cancer cell growth and proliferation,. Here we show that mTORC1 regulates polyamine dynamics, a metabolic route that is essential for oncogenicity. Through the use of integrative metabolomics in a mouse model and human biopsies of prostate cancer, we identified alterations in tumours impacting on the production of decarboxylated S-adenosylmethionine (dcSAM) and polyamine synthesis. Mechanistically, this metabolic rewiring stems from mTORC1-dependent regulation of S-adenosylmethionine decarboxylase 1 (AMD1) stability. This novel molecular regulation was validated in murine and human cancer specimens. AMD1 was upregulated in prostate cancer specimens with activated mTORC1. Conversely, samples from a clinical trial with the mTORC1 inhibitor everolimus exhibited a predominant decrease in AMD1 immunoreactivity that was associated to a decrease in proliferation, in line with the requirement of dcSAM production for oncogenicity. These findings provide fundamental information about the complex regulatory landscape controlled by mTORC1 to integrate and translate growth signals into an oncogenic metabolic program

    Mexico ants: incidence and abundance along the Nearctic–Neotropical interface

    No full text
    International audienceto explore different aspects of the population and community research of ants at different spatial scales, and to aid in the establishment of conservation policies and actions. There are no copyright restrictions. Please cite this data paper when using its data for publications or teaching events

    Mexico's Ants: Who are They and Where do They Live?

    No full text
    International audienc

    Evolution over Time of Ventilatory Management and Outcome of Patients with Neurologic Disease∗

    No full text
    OBJECTIVES: To describe the changes in ventilator management over time in patients with neurologic disease at ICU admission and to estimate factors associated with 28-day hospital mortality. DESIGN: Secondary analysis of three prospective, observational, multicenter studies. SETTING: Cohort studies conducted in 2004, 2010, and 2016. PATIENTS: Adult patients who received mechanical ventilation for more than 12 hours. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Among the 20,929 patients enrolled, we included 4,152 (20%) mechanically ventilated patients due to different neurologic diseases. Hemorrhagic stroke and brain trauma were the most common pathologies associated with the need for mechanical ventilation. Although volume-cycled ventilation remained the preferred ventilation mode, there was a significant (p < 0.001) increment in the use of pressure support ventilation. The proportion of patients receiving a protective lung ventilation strategy was increased over time: 47% in 2004, 63% in 2010, and 65% in 2016 (p < 0.001), as well as the duration of protective ventilation strategies: 406 days per 1,000 mechanical ventilation days in 2004, 523 days per 1,000 mechanical ventilation days in 2010, and 585 days per 1,000 mechanical ventilation days in 2016 (p < 0.001). There were no differences in the length of stay in the ICU, mortality in the ICU, and mortality in hospital from 2004 to 2016. Independent risk factors for 28-day mortality were age greater than 75 years, Simplified Acute Physiology Score II greater than 50, the occurrence of organ dysfunction within first 48 hours after brain injury, and specific neurologic diseases such as hemorrhagic stroke, ischemic stroke, and brain trauma. CONCLUSIONS: More lung-protective ventilatory strategies have been implemented over years in neurologic patients with no effect on pulmonary complications or on survival. We found several prognostic factors on mortality such as advanced age, the severity of the disease, organ dysfunctions, and the etiology of neurologic disease

    International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

    No full text
    We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN
    corecore